Clinical trial

Exploratory Trial to Assess the Functionality of an Integrated Call Center for the Digital Medicine System

NCT02722967

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2016-03-01

PhasePHASE2

Study timeline

Study start (unknown)2016-03-01Date precision: month

Registry last updated2018-05-23

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Schizophreniaunresolved

Major Depressive Disorderunresolved

Bipolar I Disorderunresolved

Interventions

Aripiprazole + IEM (Ingestible Event Marker)DRUG

Sponsors & collaborators

Otsuka Pharmaceutical Development & Commercialization, Inc.lead sponsor

Mapped research locations

DurhamNorth Carolina, United States1 RochesterNew York, United States1 RichmondVirginia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02722967 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.